SPLIT SEPTUM INJECTION SITES

SPLIT SEPTUM INJECTION SITES is an FDA 510(k)-cleared medical device (K041042) manufactured by Fresenius Medical Care North America. This device is classified under the General Hospital specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on July 15, 2004. Regulation: 8.